Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-14

Clinical Trial Update: AM-101 in the Treatment of Acute Tinnitus 3 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for AM-101 in the treatment of acute tinnitus (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AM 101

Snippet

Sponsor: Auris Medical AG | Conditions: Tinnitus | Phase 3 | Status: COMPLETED